Total Funding: 44051761.0
Headquarters: Pittsburgh, Pennsylvania, United States
Funding Status: Early Stage Venture
Employee Number: 11-50
Estimated Revenue: $1M to $10M
Last Funding Type: Grant
Technology: Anti-infective Drugs
Last Funding Date: 2022-01-05
Investors Number: 11.0
Founded Date: 2013-01-01
Industry: Early Drug Development